Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuria Mulet-Margalef

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Oncotargets and Therapy|December 24, 2016
Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectivesNuria Mulet-Margalef, Xavier Garcia-Del-Muro
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|May 9, 2012
[Neuroendocrine tumors: the age of targeted therapies]Jaume Capdevila, Guillem Argilés, Nuria Mulet-Margalef, et al.
International Journal of Molecular Sciences|February 4, 2021
Tumor-Associated Microbiome: Where Do We Stand?Marc Oliva, Nuria Mulet-Margalef, Maria Ochoa-De-Olza, et al.
Cancer Chemotherapy and Pharmacology|November 14, 2015
Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)Xavier Garcia del Muro, Enrique de Alava, Vicenç Artigas, et al.
Gut|April 14, 2026
Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapyMar Iglesias Coma, Jordi Badia-Ramentol, Carolina Martinez-Ciarpaglini, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Oncotargets and Therapy|December 24, 2016
Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectivesNuria Mulet-Margalef, Xavier Garcia-Del-Muro
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|May 9, 2012
[Neuroendocrine tumors: the age of targeted therapies]Jaume Capdevila, Guillem Argilés, Nuria Mulet-Margalef, et al.
International Journal of Molecular Sciences|February 4, 2021
Tumor-Associated Microbiome: Where Do We Stand?Marc Oliva, Nuria Mulet-Margalef, Maria Ochoa-De-Olza, et al.
Cancer Chemotherapy and Pharmacology|November 14, 2015
Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)Xavier Garcia del Muro, Enrique de Alava, Vicenç Artigas, et al.
Gut|April 14, 2026
Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapyMar Iglesias Coma, Jordi Badia-Ramentol, Carolina Martinez-Ciarpaglini, et al.
Pageof 1